Autologous specific dendritic cell therapy for colorectal cancer (Hebei Litongkang Biotechnology)
自体特异性树突状细胞治疗非小细胞性肺癌（河北利同康生物）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameAutologous specific dendritic cell therapy for colorectal cancer (Hebei Litongkang Biotechnology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesHebei Litongkang Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesHebei Litongkang Biotechnology Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A